GeminIQ Website Logo

Viewing ZBH free

Subscribe for full history, 50+ metrics, screener, watchlist...

ZIMMER BIOMET HOLDINGS, INC.

ZBH

Companies in Orthopedic, Prosthetic & Surgical Appliances & Supplies

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
4245921,2935571,385526569420393416292320
Accounts Receivable Net Current
1,7291,7041,5981,6111,5331,4811,4821,4181,4461,4421,3411,367
Inventory Net
2,2472,2862,4842,4542,2442,2352,3692,3702,3882,3852,3232,276
Prepaid Expense And Other Assets Current
563537460431428430445431404366416425
Assets Current
4,9635,1205,8355,0545,5904,6724,8644,6394,6324,6104,3724,388
Property Plant And Equipment Net
2,2122,2072,1942,1762,0652,0492,1072,1032,0912,0602,0321,975
Goodwill
9,9329,9479,7029,7108,9898,9518,9128,8258,7928,8198,7108,744
Intangible Assets Net Excluding Goodwill
4,5484,7174,7404,8914,4684,5984,6654,7074,7344,8564,8925,028
Other Assets Noncurrent
1,0681,1001,0171,0351,0721,0961,1721,2461,2041,1521,2111,160
Assets
22,72223,09223,48822,86522,18421,36521,72021,52021,45221,49721,21721,294
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
361303315349301195322342370411320355
Accrued Income Taxes Current
--------70619782
Employee Related Liabilities Current
294-----------
Other Liabilities Current
1,0331,6941,4881,5311,3941,3931,5361,3891,3861,5471,3001,278
Long Term Debt Current
1,1765876008206008631,7131,878970900355520
Liabilities Current
2,8642,5842,4032,7002,2952,4513,5713,6082,7972,8572,0722,234
Deferred Income Tax Liabilities Net
250244---353--370358465475
Accrued Income Taxes Noncurrent
--------276274403376
Other Liabilities Noncurrent
6316268068799097441,0281,205577926632642
Long Term Debt Noncurrent
6,2956,9327,5136,7536,5765,3424,7383,9574,8264,8685,1275,189
Liabilities
10,04010,38610,72210,3319,7808,8899,3378,7718,8469,0098,6998,916
Common Stock Value
333333333333
Additional Paid In Capital Common Stock
10,19910,17910,15610,10810,08710,03810,0189,9759,9469,8469,8019,766
Retained Earnings Accumulated Deficit
11,80311,61111,51911,33511,23011,09510,90410,70310,50910,38510,0159,902
Accumulated Other Comprehensive Income Loss Net Of…
-190-206-284-285-287-263-202-195-211-191-187-178
Treasury Stock Value
-9,141-8,889-8,637-8,637-8,637-8,406-8,348-7,744-7,649-7,562-7,122-7,122
Stockholders Equity
12,67312,70612,76612,52512,39512,47612,37512,74912,60612,48812,51112,379
Minority Interest
8810998988877
Liabilities And Stockholders Equity
22,72223,09223,48822,86522,18421,36521,72021,52021,45221,49721,21721,294
Common Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized
1,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,000
Common Stock Shares Issued
319319319318318318317317317316316316
Treasury Stock Common Shares
126123121121121118118112112111107107

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20263.14%6.12%10.21%---------
20251.87%1.35%8.09%7.79%-0.19%4.93%11.39%3.68%-0.82%-5.62%-5.45%-16.40%
2024-1.73%-8.95%-6.51%9.12%2.28%-3.06%0.37%-2.45%0.00%3.15%-8.59%-9.49%
2023-10.74%0.85%-0.38%-12.88%-11.66%-20.78%11.37%15.12%15.11%-3.10%-3.46%-5.92%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
1.73
1.98
2.43
1.87
2.44
1.91
1.36
1.29
1.66
1.61
2.11
1.96
Quick Ratio
0.75
0.89
1.20
0.80
1.27
0.82
0.57
0.51
0.66
0.65
0.79
0.76
Working Capital
2.10B
2.54B
3.43B
2.35B
3.30B
2.22B
1.29B
1.03B
1.83B
1.75B
2.30B
2.15B
Leverage & Debt
Debt to Equity
0.79
0.82
0.84
0.82
0.79
0.71
0.75
0.69
0.70
0.72
0.70
0.72
Interest Coverage TTM
3.99
3.75
4.71
4.82
5.62
5.90
6.06
6.09
5.97
6.35
4.63
4.73
Debt Ratio
0.44
0.45
0.46
0.45
0.44
0.42
0.43
0.41
0.41
0.42
0.41
0.42
Efficiency & Turnover
Asset Turnover TTM
0.37
0.37
0.35
0.35
0.35
0.36
0.35
0.35
0.35
0.35
0.34
0.34
Days Sales Outstanding TTM
70.79
70.62
70.16
70.57
70.64
69.47
67.81
67.55
69.24
69.70
65.67
67.20
Receivables Turnover TTM
5.16
5.17
5.20
5.17
5.17
5.25
5.38
5.40
5.27
5.24
5.56
5.43
Per Share Metrics
Diluted EPS TTM
3.89
3.55
4.05
4.15
4.57
4.43
5.34
4.83
4.68
4.88
2.26
2.41
Free Cash Flow Per Share TTM
7.47
7.44
7.50
7.44
7.34
6.38
6.75
6.17
5.86
6.18
4.53
5.25
Dividend Per Share TTM
0.97
0.96
0.96
0.97
0.98
0.97
0.98
0.97
0.97
0.96
0.96
0.97
Margin Metrics
Gross Profit Margin TTM
70.03%
69.71%
71.44%
71.06%
71.05%
71.46%
71.78%
71.78%
71.88%
71.82%
71.63%
71.72%
Operating Profit Margin TTM
14.02%
13.34%
16.63%
16.09%
17.04%
16.74%
16.47%
16.45%
16.32%
17.28%
12.30%
12.15%
Net Profit Margin TTM
9.05%
8.57%
10.05%
10.51%
11.86%
11.77%
14.27%
13.25%
12.94%
13.85%
6.52%
7.03%
Growth Metrics
Net Revenue Growth (1Y)
9.23%
7.20%
5.47%
4.11%
3.30%
3.85%
4.34%
4.58%
4.85%
6.55%
5.62%
4.17%
Net Income Growth (1Y)
-16.63%
-21.98%
-25.73%
-17.47%
-5.29%
-11.74%
128.32%
97.11%
114.22%
342.52%
71.15%
121.01%
EPS Growth (1Y)
-14.96%
-19.98%
-24.15%
-14.22%
-2.29%
-9.30%
135.77%
99.89%
118.61%
344.43%
71.89%
122.07%
Valuation Metrics
P/E TTM
23.10
25.12
24.05
21.70
24.34
23.38
19.80
21.95
27.49
24.22
48.14
58.38
P/B TTM
1.39
1.39
1.52
1.43
1.79
1.69
1.73
1.72
2.10
1.99
1.83
2.39
P/S TTM
2.09
2.15
2.42
2.28
2.89
2.75
2.83
2.91
3.56
3.35
3.14
4.10
Market Cap
17.59B
17.71B
19.36B
17.86B
22.22B
21.13B
21.46B
21.89B
26.50B
24.80B
22.85B
29.54B
Enterprise Value
24.63B
24.64B
26.18B
24.88B
28.01B
26.81B
27.34B
27.30B
31.90B
30.15B
28.04B
34.93B
Calculated Values
Free Cash Flow TTM
1.46B
1.47B
1.48B
1.47B
1.46B
1.30B
1.37B
1.27B
1.20B
1.29B
945.70M
1.10B
Net Debt
7.05B
6.93B
6.82B
7.02B
5.79B
5.68B
5.88B
5.41B
5.40B
5.35B
5.19B
5.39B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-05-29Sale
Owner: Yi, Sang
Title: Group President, Asia Pacific
Shares: 5,000
Price/Share: $82.65
Value: $413,250.00
Shares Owned: 27,251
Relationship: Officer
Ownership: Direct
2026-03-12Sale
Owner: Winkler, Lori
Title: SVP and CHRO
Shares: 2,650
Price/Share: $94.66
Value: $250,849.00
Shares Owned: 10,224
Relationship: Officer
Ownership: Direct
2026-02-12Sale
Owner: Yi, Sang
Title: Group President, Asia Pacific
Shares: 1,000
Price/Share: $96.49
Value: $96,490.00
Shares Owned: 17,670
Relationship: Officer
Ownership: Direct
2025-09-11Sale
Owner: Yi, Sang
Title: Group President, Asia Pacific
Shares: 1,200
Price/Share: $103.59
Value: $124,308.00
Shares Owned: 18,584
Relationship: Officer
Ownership: Direct
2025-09-08Sale
Owner: Winkler, Lori
Title: SVP and CHRO
Shares: 1,500
Price/Share: $104.15
Value: $156,225.00
Shares Owned: 6,833
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
89.82%
Inst. Shares: 175,146,279
Shares Outstanding: 195,000,000
2025-12-31
90.54%
Inst. Shares: 179,262,641
Shares Outstanding: 198,000,000
2025-09-30
84.45%
Inst. Shares: 167,298,281
Shares Outstanding: 198,100,000
2025-06-30
85.28%
Inst. Shares: 168,774,484
Shares Outstanding: 197,900,000
2025-03-31
79.90%
Inst. Shares: 158,924,719
Shares Outstanding: 198,900,000

ZIMMER BIOMET HOLDINGS, INC. (ZBH) — SEC Financial Statements & Analysis

ZIMMER BIOMET HOLDINGS, INC. (ZBH) is a orthopedic, prosthetic & surgical appliances & supplies company, incorporated in DE. ZIMMER BIOMET HOLDINGS, INC. trades on ZBH: NYSE as: ZBH. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), ZIMMER BIOMET HOLDINGS, INC. reported a 9.23% year-over-year revenue growth, a Gross Profit Margin of 70.03% (TTM), a Debt-to-Equity ratio of 0.79x, a Price-to-Sales (P/S) ratio of 2.09x (TTM), a Price-to-Book (P/B) ratio of 1.39 (TTM), at a market cap of $17.59B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
9.23%
Gross Profit Margin TTM
70.03%
Debt To Equity
0.79x
P/S TTM
2.09x
P/B TTM
1.39
Market Cap
$17.59B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is ZIMMER BIOMET HOLDINGS, INC. in?

ZIMMER BIOMET HOLDINGS, INC. (ZBH) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.

What is ZBH's market cap?

ZIMMER BIOMET HOLDINGS, INC. (ZBH) has a market capitalization of $17.59B as of 2026-03-31.

What is ZBH's P/E ratio?

ZIMMER BIOMET HOLDINGS, INC. (ZBH)'s trailing twelve month P/E ratio is 23.10x as of 2026-03-31.

What exchange does ZBH trade on?

ZIMMER BIOMET HOLDINGS, INC. (ZBH) trades on the ZBH: NYSE.

Where is ZIMMER BIOMET HOLDINGS, INC. incorporated?

ZIMMER BIOMET HOLDINGS, INC. is incorporated in DE.

Research Faster.
Invest Smarter.

ZIMMER BIOMET HOLDINGS, INC. (ZBH) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.